Cytosorbents (CTSO) Interest & Investment Income (2010 - 2026)
Cytosorbents (CTSO) reported Interest & Investment Income of -$857000.0 for Q1 2026, down 41.65% on a YoY basis from -$1.5 million in Q1 2025, and down 14.88% quarter-over-quarter from -$746000.0 in Q4 2025.
Cytosorbents (CTSO) Interest & Investment Income (2010 - 2026) Analysis & Trends
Cytosorbents has reported Interest & Investment Income for 17 years, with the latest figure at -$857000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 41.65% year-over-year to -$857000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.9 million (down 43.42% YoY), and the FY2025 full-year result was -$2.6 million, down 86.7% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$857000.0, down from -$746000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $53748.0 in Q4 2022, with the low at -$857000.0 in Q1 2026.
- Historically, Interest & Investment Income has averaged -$287820.6 across 5 years, with a median of -$63170.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 337.19% — and 2025, when it sank 8993.64%.
- Cytosorbents' Interest & Investment Income stood at $53748.0 in 2022, then slumped by 197.17% to -$52229.0 in 2023, then slumped by 1094.74% to -$624000.0 in 2024, then fell by 19.55% to -$746000.0 in 2025, then dropped by 14.88% to -$857000.0 in 2026.
- The last three Interest & Investment Income figures came in at -$857000.0 (Q1 2026), -$746000.0 (Q4 2025), and -$645000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 33.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Cytosorbents | 25.72 Mn | 20.92 Mn | 6.13 Mn | -857,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -857,000.00 |
| Dec 31, 2025 | -746,000.00 |
| Sep 30, 2025 | -645,000.00 |
| Jun 30, 2025 | -616,000.00 |
| Mar 31, 2025 | -605,000.00 |
| Dec 31, 2024 | -624,000.00 |
| Sep 30, 2024 | -588,000.00 |
| Jun 30, 2024 | -180,000.00 |
| Mar 31, 2024 | -6,653.00 |
| Dec 31, 2023 | -52,229.00 |
| Sep 30, 2023 | -33,670.00 |
| Jun 30, 2023 | -8,821.00 |
| Mar 31, 2023 | -63,170.00 |
| Dec 31, 2022 | 53,748.00 |
| Sep 30, 2022 | 46,845.00 |
| Jun 30, 2022 | 23,973.00 |
| Mar 31, 2022 | 8,027.00 |
| Dec 31, 2021 | 12,294.00 |
| Sep 30, 2021 | 12,766.00 |
| Jun 30, 2021 | 13,072.00 |